0.39
price down icon4.88%   -0.02
after-market アフターアワーズ: .38 -0.01 -2.56%
loading

Glycomimetics Inc (GLYC) 最新ニュース

pulisher
06:46 AM

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC - GlobeNewswire Inc.

06:46 AM
pulisher
12:45 PM

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders - Marketscreener.com

12:45 PM
pulisher
11:01 AM

What Do Wall Street Analysts Think About GlycoMimetics Inc (NASDAQ: GLYC) Stock? - Stocks Register

11:01 AM
pulisher
Nov 03, 2024

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc.GLYC - PR Newswire

Nov 03, 2024
pulisher
Nov 01, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders - The Malaysian Reserve

Nov 01, 2024
pulisher
Oct 31, 2024

GlycoMimetics’ Acquisition of Crescent Biopharma - Global Legal Chronicle

Oct 31, 2024
pulisher
Oct 31, 2024

GlycoMimetics, Canaan, PayPal: 3 Stocks Retail Is Most Bullish On Today - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc.GLYC - Business Wire

Oct 31, 2024
pulisher
Oct 31, 2024

3 Penny Stocks to Watch Now, 10/31/24 - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

GlycoMimetics Announces Merger Agreement with Crescent Biopharma: A Look at the Details - Defense World

Oct 31, 2024
pulisher
Oct 30, 2024

GlycoMimetics To Acquire Crescent Biopharma - FinSMEs

Oct 30, 2024
pulisher
Oct 30, 2024

GlycoMimetics soars on news of M&A deal with Crescent Biopharma - The Pharma Letter

Oct 30, 2024
pulisher
Oct 30, 2024

GlycoMimetics Announces Merger with Crescent Biopharma - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

GlycoMimetics Insider Confidence Rewarded, Stock Hits US$11m Market Cap - Simply Wall St

Oct 30, 2024
pulisher
Oct 30, 2024

Biotech Up Over +100% Premarket Following Merger And Funding Announcement - MSN

Oct 30, 2024
pulisher
Oct 29, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CPTN, GLYC, ARC on Behalf of Shareholders - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Profire Energy, Inc. (Nasdaq – PFIE), Cepton, Inc. (Nasdaq – CPTN), GlycoMimetics, Inc. (Nasdaq – GLYC), ARC Document Solutions, Inc. (NYSE – ARC) - ForexTV.com

Oct 29, 2024
pulisher
Oct 29, 2024

Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results - Benzinga

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics Stock Triples To Become Top Gainer On Crescent Biopharma Merger Deal: Retail Goes Wild - Barchart

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics Shares Are Soaring Tuesday: Here's Why - Benzinga

Oct 29, 2024
pulisher
Oct 29, 2024

Crescent Inks Oncology Merger With $200M In Private Funding - Law360

Oct 29, 2024
pulisher
Oct 29, 2024

TSX Composite Weight Index (TXCE) QuotePress Release - The Globe and Mail

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics Agrees to Acquire Crescent Biopharma - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

Crescent rolls up to Glycomimetics merger, $200M in new bread - BioWorld Online

Oct 29, 2024
pulisher
Oct 29, 2024

Shareholder Alert: Ademi LLP Investigates Whether GlycoMimetics, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire

Oct 29, 2024
pulisher
Oct 29, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE and GLYC on Behalf of Shareholders - Marketscreener.com

Oct 29, 2024
pulisher
Oct 29, 2024

TSX 60 ESG Index (TSXE) QuotePress Release - The Globe and Mail

Oct 29, 2024
pulisher
Oct 29, 2024

US Stocks Mixed; McDonald's Posts Upbeat Earnings - Benzinga

Oct 29, 2024
pulisher
Oct 29, 2024

TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail

Oct 29, 2024
pulisher
Oct 29, 2024

Crescent inks GlycoMimetics merger, securing Nasdaq listing and $200M for hot cancer program - Fierce Biotech

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics enters acquisition agreement with Crescent Biopharma - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Rockville biotech GlycoMimetics to be acquired - The Business Journals

Oct 29, 2024
pulisher
Oct 29, 2024

GLYC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of GlycoMimetics, Inc. Is Fair to Shareholders - Business Wire

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics skyrockets on buyout deal - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics Agrees to Be Taken Private by Crescent Biopharma - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

Glycomimetics Shares Fall After Leukemia Treatment Trial Misses Key Goal - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics to acquire Crescent Biopharma in a strategic merger - Investing.com

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma - Business Wire

Oct 29, 2024
pulisher
Oct 29, 2024

GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - StockTitan

Oct 29, 2024
pulisher
Oct 27, 2024

S&P 500 Energy [Sector] (SREN) QuotePress Release - The Globe and Mail

Oct 27, 2024
pulisher
Oct 21, 2024

GlycoMimetics (NASDAQ:GLYC) Now Covered by StockNews.com - Defense World

Oct 21, 2024
pulisher
Oct 14, 2024

Analytical Lens: Exploring GlycoMimetics Inc (GLYC)’s Financial Story Through Ratios - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

TD Cowen downgrades GlycoMimetics Inc (GLYC) rating to a Hold - Knox Daily

Oct 14, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Buys 685,151 Shares of GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World

Oct 13, 2024
pulisher
Oct 10, 2024

10% Owner Invus Public Equities, L.P. sale 260,873 shares of GlycoMimetics Inc [GLYC] - Knox Daily

Oct 10, 2024
pulisher
Oct 10, 2024

GLYC Stock on the Rise: A Promising Investment - The InvestChronicle

Oct 10, 2024
pulisher
Oct 10, 2024

Financial Fitness Check: Examining GlycoMimetics Inc (GLYC)’s Key Ratios - The Dwinnex

Oct 10, 2024
pulisher
Oct 09, 2024

GlycoMimetics stock plunges to 52-week low of $0.14 - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

GlycoMimetics stock plunges to 52-week low of $0.14 By Investing.com - Investing.com South Africa

Oct 09, 2024
pulisher
Oct 03, 2024

Balance Sheet Insights: GlycoMimetics Inc (GLYC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oct 03, 2024
pulisher
Oct 03, 2024

GlycoMimetics Inc [GLYC] Records 50-Day SMA of $0.1817 - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

Understanding GlycoMimetics Inc Inc. (GLYC) Price Performance Through Chart Patterns - The InvestChronicle

Oct 03, 2024
pulisher
Oct 02, 2024

GLYC’s valuation metrics: A comprehensive analysis - US Post News

Oct 02, 2024
pulisher
Sep 28, 2024

GlycoMimetics GAAP EPS of -$0.17 in-line - MSN

Sep 28, 2024
pulisher
Sep 27, 2024

GlycoMimetics Inc [GLYC] Records 50-Day SMA of $0.1928 - Knox Daily

Sep 27, 2024
pulisher
Sep 27, 2024

GLYC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Sep 27, 2024
pulisher
Sep 26, 2024

Sickle cell mechanisms that could fill the hole left by Pfizer’s Oxbryta withdrawal - BioCentury

Sep 26, 2024
pulisher
Sep 24, 2024

GlycoMimetics Inc [GLYC] Stock sold by Insider Invus Public Equities, L.P. for $50009.0 - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Capital One Initiates Coverage of GlycoMimetics (GLYC) with Overweight Recommendation - MSN

Sep 24, 2024
pulisher
Sep 24, 2024

Market Insights: GlycoMimetics Inc (GLYC)’s Notable Drop of -0.18, Closing at 0.16 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Is GlycoMimetics Inc (GLYC) a threat to investors? - US Post News

Sep 24, 2024
pulisher
Sep 19, 2024

GlycoMimetics Inc [NASDAQ: GLYC] Sees Decrease in Stock Value - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

India Glycols receives revision in credit rating from CARE - Business Standard

Sep 19, 2024
pulisher
Sep 19, 2024

CARE Ratings affirms 'A-' rating of India Glycols with 'stable' outlook - Business Standard

Sep 19, 2024
pulisher
Sep 19, 2024

StockNews.com Initiates Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World

Sep 19, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):